Plain-English translation of NCT07651436 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Depression is very common in people receiving hemodialysis (a lifesaving treatment for kidney failure), but it often goes unnoticed. This study is testing whether nurses can reliably screen for depression using a short, validated questionnaire called the Hospital Anxiety and Depression Scale. The goal is to develop a simple routine way to catch depression early so that patients can get help.
People on dialysis face many physical and emotional challenges—long treatment sessions, strict diets, fatigue, and life restrictions—that make depression much more likely than in the general population. Currently, depression in dialysis patients is often missed because there is no standard screening method built into routine care, even though it leads to worse health outcomes and quality of life.
You likely qualify if…
You likely don't qualify if…
You would complete a short mood questionnaire (the depression screening tool) during or around your regular dialysis visits. Your answers would be reviewed, and if the screening suggests depression, your doctor will be notified so they can talk with you and arrange appropriate support or treatment. The study involves no new medications or procedures—just an additional screening conversation.
AI-generated summary from trial data · Aug 4, 2026 · Not medical advice
France